OXFORD, England, Feb. 27, 2026 /PRNewswire/ — Optellum, the leading AI-enabled solution for earlier lung cancer detection, is thrilled to announce that it has received Therapeutic Goods Administration (TGA) class IIb approval in Australia for the Virtual Nodule Clinic (VNC) platform to support early lung cancer diagnosis. This important regulatory milestone was achieved after a rigorous review of technical documentation and validation studies, recognizing its safety and performance for clinical use. VNC helps identify, triage, and manage patients with pulmonary nodules, and includes a clinically validated AI decision support tool, lung cancer prediction (LCP) AI, already used in the US and EU/UK for nodule risk stratification.

Lung cancer remains a major health challenge in Australia, with over 15,000 new diagnoses each year and low 5-year survival rates around 27%. [1] Delayed detection of incidental findings, inconsistent follow-up, and growing pressure on imaging and specialist services continue to contribute to later diagnosis. These pain points can lead to unnecessary anxiety for patients and missed opportunities for earlier intervention, highlighting the need for tools that support timely recognition and coordinated health systems.

This TGA clearance poises Optellum to help thousands of patients in Australia by supporting earlier and more consistent identification of incidental lung nodules. By helping care teams prioritize higher-risk findings and streamline follow-up more efficiently, VNC aims to reduce delays and uncertainty along the lung cancer care pathway. This clearance marks an important step in bringing validated AI tools into everyday clinical workflows, without replacing clinical judgment.

Optellum remains committed to working with Australian health systems to support responsible AI adoption that improves patient care quality and experience. This milestone reflects Optellum’s broader mission to help patients move from detection to diagnosis with speed, greater clarity, and confidence.

About Optellum
Optellum is a commercial-stage AI healthcare company dedicated to revolutionizing early diagnosis and treatment of lung disease, starting with one of the deadliest, lung cancer.

Optellum’s flagship product, Virtual Nodule Clinic (VNC) with Lung Cancer Prediction AI (LCP), is the world’s first and only FDA-cleared and reimbursed software-as-a-medical-device (SaMD) solution for AI-powered lung cancer prioritization and diagnostic support. Clinicians trust the Optellum solution to aid them in making the most appropriate life-saving treatment decisions for their patients. Backed by real-world clinical evidence, Optellum’s solution accelerates the diagnostic care pathway by enabling early patient identification, enhancing prioritization, and improving clinicians’ efficiency, reducing time to guideline-recommended treatment. Optellum VNC is FDA cleared, CE-MDR marked, TGA approved, and UKCA marked.

Optellum is headquartered in Oxford, UK, and has an office at the Texas Medical Center in Houston, Texas, US.

Media Contact
marketing@optellum.com

Logo – https://laotiantimes.com/wp-content/uploads/2026/02/optellum_logo.jpg

• As the 2026 Best Workplaces for Women Australia List set to drop, Great Place To Work’s GM has thoughts on International Women’s Day, performative targets and being a voice for the next generation.

SYDNEY, Feb. 27, 2026 /PRNewswire/ — Rebecca Moulynox has a low tolerance for cupcakes. Not the bakery treats themselves, she’s not a monster, it’s the specific genus of ballerina pink or bubble-gum purple cupcake that appears in office kitchens every March. You know the ones, they’re always spread out next to a sagging “Happy International Women’s Day!” sign with several complicated hashtags.

“I find the morning tea bit condescending,” she says of the scene. “It’s superficial, performative, and that bit feels ridiculous to me. But I love hearing about what amazing women are doing, and International Women’s Day does create opportunities for these stories to come out.” she says.

Moulynox is the General Manager for Great Place To Work across Australia and New Zealand, which means she sits in the nexus of workplace culture and the data that measures it, two things corporate Australia absolutely loves to invoke but rarely reconcile. On March 5 the global authority on workplace culture will release their annual Best Workplaces for Women Australia List, timed to land days before International Women’s Day.

Women, Work And The Numbers That Matter 

The Best Workplaces for Women list isn’t organisations marking their own homework. Companies need at least 100 employees, with a minimum of 50 women. At least 30 per cent of the total workforce must be female, and 20 per cent of management excluding the executive suite, where the numbers can be inflated by a single appointment.

From there, the methodology layers survey scores from women employees with Workplace Gender Equality Agency benchmarks, awarding extra points to companies that employ more women than the industry average. A gender pay gap below 10 per cent attracts more points; if the gap blows out beyond 25 per cent, companies lose them.

“They don’t mess around, it’s a really rigorous methodology. And I genuinely like working on the list because I’ve used it myself. I want to know who has good flexible work and fair pay practices, and who has women in leadership,” she says. “I don’t want to go and work for a company with 50 men in charge and no women.” 

This year’s list surfaces some genuinely striking data. “Unfortunately there are still plenty of companies in Australia where up to 70 per cent of their workforce is women and the gender pay gap is still 35 per cent in favour of men,” Moulynox says. “When you see numbers like that you kind of go, how do you even manage that? There must be absolutely no work going on to really address the pay parity if it’s still that big when you’ve got more women than men in a company.”

Before becoming the GM of Great Place To Work for Australia and New Zealand, Moulynox spent years in finance, a sector notorious for making gender targets with the enthusiasm of someone doing community service. She has opinions about this, too.

“Companies put targets in place and try to track towards them, but in my experience, targets don’t really move the needle on people understanding why it matters,” she says. “If you really want to make actual change, you need leadership at the top to genuinely understand the business impact.”

She floats a scenario that a company chasing a 40 per cent female headcount can simply “hire them all as EAs and clerical administration” to hit the target. What separates genuine commitment from compliance? “I think if an organisation really cares about equality, they track it for the right reasons, not because they have to.”

Finding Your Voice And Using It To Help 

“A lot of the time women, particularly in male‑dominated industries like tech or finance, still try not to rock the boat,” Moulynox says. “We’re often the ones bringing harmony and working through things with gentle influence rather than sheer force of will.”

It is the kind of emotional labour that rarely shows up in a performance review. “As I’ve gotten older and recognised my own value and what I bring to the table, I’ve become more confident about saying when I actually know what I’m talking about.”

“We don’t have to be forceful, but we also don’t have to be meek and mild, making sure everyone’s happy. You can say, ‘We keep having the same conversation with the same people. Let’s change that.'”

That earned confidence, she believes, comes with an obligation. “Flexibility has been framed as this unambiguous win for women and for a lot of senior women it genuinely is,” Moulynox says. “But for young women, especially in their first three to five years, early‑career development has always depended on proximity. Being in the room, seeing how decisions get made, having those informal mentoring moments. When you move work online without redesigning how development happens, those moments just disappear, and they disappear unevenly.”

“I think it’s really important for women who hold any type of leadership role or role of influence to not just mentor, but sponsor and champion the younger generation,” she says. “When we look across five years of our data, the gap between junior and senior women is a cliff. Junior women report roughly half the recognition, half the sense that promotions are fair, and barely half the enthusiasm about coming to work that senior women do and that pattern is so consistent. We need to make space for them. Be their opportunity advocates.”

“That matters even more when you look at where AI is heading,” Moulynox says. “Young women are concentrated in exactly the administrative and junior support roles that generative AI is coming for first. If those entry‑level roles disappear and we haven’t built real pathways into higher‑value work, we shrink the whole pipeline of future female leaders.”

The unfrosted truth is that when it comes to International Women’s Day, women don’t want cake; they want fairness, a seat at the table and transparency – and the data shows they can tell the difference, especially the young women watching how employers treat the floor, not just the ceiling.

The 2026 Best Workplaces for Women Australia List will be released on 5 March, in the lead-up to International Women’s Day. To find out which 50 companies made the list subscribe here.

Media Contact:
Alice Williams
alice.williams@greatplacetowork.com 

Highlights:

• First participant enrolled and dosed with NUZ-001 in Regimen I of the HEALEY ALS Platform Trial evaluating NUZ-001 for the treatment of ALS
• Approximately 160 participants with ALS will be enrolled in a 36-week randomised, double-blind, placebo-controlled adaptive Phase 2/3 clinical trial in leading ALS clinical centres across the United States
• Follows a successful Phase 1 clinical program in a small study population (n=12) in people living with ALS, which showed encouraging preliminary signals of efficacy and NUZ-001 was safe and well-tolerated
• Study is expected to complete enrolment in H2 CY2026

MELBOURNE, Australia, Feb. 27, 2026 /PRNewswire/ — Neurizon® Therapeutics Limited (ASX: NUZ & NUZOA; OTCQB: NUZTF) (“Neurizon” or “the Company”), a clinical-stage biotechnology company dedicated to advancing innovative treatments for neurodegenerative diseases, is pleased to announce that the first participant has been dosed in Regimen I of the HEALEY ALS Platform Trial evaluating Neurizon’s lead candidate, NUZ-001, for the treatment of amyotrophic lateral sclerosis (ALS).

HEALEY ALS Platform Trial

The HEALEY ALS Platform Trial (ClinicalTrials.gov identifier: NCT04297683) is a multicentre, double-blind, placebo-controlled adaptive Phase 2/3 clinical trial conducted by the Sean M. Healey & AMG Center for ALS at Mass General Hospital Brigham in the United States (US), created in partnership with the Network of Excellence for ALS (NEALS). Entry into the HEALEY ALS Platform Trial is competitive, with drug candidates reviewed and selected by expert committees based on scientific merit and evidence of potential benefit in ALS. The goal of the HEALEY ALS Platform Trial is to accelerate the development of potential new ALS therapies. The trial evaluates multiple investigational drugs (Regimens) concurrently under a single framework or master protocol, leveraging shared infrastructure across over 70 participating clinical sites. By streamlining start-up and enrollment processes, it accelerates study execution and delivers results more efficiently.

Regimen I

Regimen I (NUZ-001) includes a randomised, placebo-controlled treatment (RCT) phase followed by an active treatment extension (ATE) phase, both with a 36-week treatment period. Approximately 160 participants with ALS will be randomised to receive either daily NUZ-001 at the recommended Phase 2 dose of 10 mg/kg or placebo at a 3:1 ratio. The primary objective is to evaluate the efficacy of NUZ-001 compared with placebo on ALS disease progression, with secondary objectives including additional measures of disease progression and safety.

Figure 1: Regimen I Study Design

Participation in the HEALEY ALS Platform Trial provides Neurizon with access to an established clinical development framework supported by the world’s most highly regarded ALS investigators and leading clinical centres across the US. This infrastructure improves trial efficiency, supports consistent data generation and facilitates ongoing engagement with regulatory authorities, including the U.S. Food and Drug Administration (FDA), as the trial progresses.

Professor Merit Cudkowicz, Principal Investigator, HEALEY ALS Platform Trial & Director, Sean M. Healey & AMG Center for ALS, Mass General Brigham, commented: “We look forward to working with Neurizon on this new regimen in the HEALEY ALS Platform Trial and implementing our updated master protocol. Beginning enrolment is a significant step for the regimen, and would not be possible without the dedication of people living with ALS and their families, collaborators, and our top trials sites.”

Managing Director and Chief Executive Officer, Dr Michael Thurn commented: “The dosing of the first participant in Regimen I of the HEALEY ALS Platform Trial marks a defining milestone for Neurizon and for NUZ-001. This study represents our registrational trial in ALS – a rigorous, adaptive Phase 2/3 program designed to generate the clinical evidence required to support potential regulatory submissions.”

“Entry into the HEALEY ALS Platform Trial reflects our scientific data package and the favourable safety and tolerability profile observed in our Phase 1 and Open Label Extension studies. The master protocol structure enables efficient study execution across leading ALS centres in the United States, while maintaining the scientific rigour required at this stage of development.”

“We are deeply grateful to the participants and their families who commit their time and energy to clinical research, often while navigating the significant challenges associated with living with ALS. For people living with ALS, urgency matters. Through this pivotal study, we are advancing NUZ-001 with scientific discipline,  operational focus, and deep respect for the ALS community as we work toward delivering meaningful progress in this devastating disease.”

This announcement has been authorized for release by the Board of Neurizon Therapeutics Limited.

About Neurizon Therapeutics Limited

Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company dedicated to advancing treatments for neurodegenerative diseases. Neurizon is developing its lead drug candidate, NUZ-001, for the treatment of ALS, which is the most common form of motor neurone disease.  Neurizon’s strategy is to accelerate access to effective ALS treatments for patients while exploring the potential of NUZ-001 for broader neurodegenerative applications. Through international collaborations and rigorous clinical programs, Neurizon is dedicated to creating new horizons for patients and families impacted by complex neural disorders.  NUZ-001 is an investigational product and is not approved for commercial use in any jurisdiction.

About the HEALEY ALS Platform Trial

The HEALEY ALS Platform Trial is a multicenter, double-blind, placebo-controlled, adaptive trial for ALS created in partnership with the Network of Excellence for ALS (NEALS). The goal of the HEALEY ALS Platform trial is to accelerate the development of potential new ALS therapies. The trial tests and evaluates multiple investigational drugs simultaneously, shares infrastructure across trial sites, and improves start up and enrollment efficiencies, allowing for fast results.

Neurizon® is a registered trademark of Neurizon Therapeutics Limited

In Wildest DeFi Experiment Yet, Humans Surrender Trading to AI in 21-Day Battle Royale Where Only One Token Survives

TERMINAL CITY, BC, Feb. 27, 2026 /PRNewswire/ — It’s actually happening. Right now. Over 1,500 crypto traders have deposited more than $6.1 million into AI agent wallets and walked away from their keyboards. They can’t execute a single trade. They can only watch as their AI agents battle it out in what might be the most insane DeFi experiment ever conceived: DX Terminal Pro.

DX TERMINAL

The Premise Sounds Like Science Fiction, But It’s Live on Base Right Now

Here’s what’s happening: Multiple memecoins just launched. Humans deposited real ETH—$6.1 million worth—into their AI agents’ wallets. Now those agents are trading 24/7 in Uniswap V4 pools. Humans? They’re locked out. They can write strategies in plain English, adjust parameters, but they cannot manually execute the trades. Only the AI agents can buy and sell.

Oh, and here’s the kicker: Every few days, the worst-performing token gets “reaped”—eliminated from existence. This continues for 21 days until only one token remains. One winner. Everyone else? They get compensated with tokens from the survivor.

“We’ve literally created financial Darwinism,” said Timothy Barton, Group Founder at DXRG. “Traders are betting they can out-strategize 1,500 other people by writing better instructions for the same AI model. Nobody can trade manually. Nobody can manipulate the market. Just pure agent-vs-agent competition with real money on the line.”

Wait… People Actually Gave AI $6.1M to Trade?

Yes. Over 1,500 participants deposited real ETH into agent-controlled vaults that they cannot manually access during the experiment. They configured their agents with behavioral parameters—risk tolerance, trade frequency, position sizing—and wrote natural-language trading strategies. Then they pressed go.

Every agent uses the same AI model (Qwen3), runs on the same infrastructure (H100 GPUs), and plays by the same rules. The only variable? Human strategy. Who can write better trading instructions? Who understands market dynamics? Who can predict what 1,500 other agents will do?

The agents can execute up to 15 actions per hour. They’re evaluating prices, monitoring competitors, executing swaps—all documented onchain. Humans can watch. They can adjust their strategies. But they cannot intervene in trades.

The Craziest Part: “Reaping”

Starting Day 7, the real chaos begins. At regular intervals, the token with the lowest market cap gets eliminated. Not just delisted—eliminated. This happens repeatedly. Tokens die. Liquidity consolidates. The pressure intensifies. By Day 21, only one token remains—battle-tested, agent-proven, and ready for public markets.

Why Would Anyone Do This?

Good question. Here’s the pitch:

Participants get to experiment with something genuinely new: collaborating with AI on high-stakes financial decisions. You’re the strategist. The AI is your execution layer. Your edge is how well you can program autonomous behavior.

And in this experiment? If your token gets reaped? You get compensated with the winner’s tokens. You’re never completely out.

The Scale of This Experiment Is Unprecedented

In May 2025, DXRG ran DX Terminal—the largest AI financial simulation ever conducted, generating 40 billion LLM tokens of data. That was play money.

This is real money. And it’s expected to generate 10x more data—potentially 1 trillion tokens of agent behavior in actual market conditions. This is the largest dataset of autonomous AI trading behavior ever created.

“This Is Either Genius or Completely Insane”

The reactions have been… mixed.

Some call it revolutionary—a glimpse into the future where humans and AI collaborate on trading, portfolio management, and financial strategy. Others call it reckless. One participant said they’re “either going to make bank or learn a very expensive lesson about blindly trusting AI to yeet into tokens called $POOPCOIN or $AIGF.”

The truth? Both might be right. DX Terminal Pro is explicitly experimental. Participants consent to an unpredictable financial system. Real capital is at risk. Agents may behave in unexpected ways. Outcomes depend on emergent behavior that nobody can fully anticipate.

But that’s exactly the point. This isn’t supposed to be safe. It’s supposed to push boundaries.

What You Need to Know:

• Trading is LIVE RIGHT NOW on Base with $6.1M+ in play
• 1,500+ participants have activated agents
• Zero human trading allowed—only AI agents can execute
• Multiple tokens competing—only one survives 21 days
• Systematic elimination starts Day 7
• All strategies visible onchain—complete transparency
• Same AI model for everyone—strategy is the only edge
• You can withdraw capital anytime—not locked in
• Real money, real risk, real data—this is not a simulation

The Fine Print (That You Should Definitely Read)

DX Terminal Pro is experimental. This is not your normal DeFi protocol. This is 1,500 AI agents with $6.1M+ making autonomous trading decisions in real-time.

Here’s what that means:

• Agents may act unpredictably. They’re AI. Weird stuff might happen.
• Real capital is at risk. You could lose everything you deposit.
• Outcomes depend on emergent behavior nobody can fully anticipate.
• This is not financial advice. Seriously. Do your own research.

If that doesn’t scare you off, welcome to the future of experimental finance.

What Happens Next?

For the next 21 days, 1,500+ AI agents will battle it out with real money in the first true Onchain Agentic Market. The trades are happening. The data is being logged. The tokens are competing.

By March 17, 2026, only one token will remain. It will graduate to public markets on Base—battle-tested by three weeks of autonomous trading, multiple elimination rounds, and pure competitive pressure.

Will the humans who wrote the best strategies win? Will unexpected agent behavior create surprise outcomes? Will this work at all?

Nobody knows. That’s the point.

About DXRG

DXRG builds experimental financial systems at the intersection of AI and blockchain. They ran the largest AI financial simulation ever in May 2025 (40 billion LLM tokens). Now they’re doing it with real money. DX Terminal Pro is the first Onchain Agentic Market—where AI agents trade, humans strategize, and the market decides who wins.

Follow the Chaos Live:

https://www.terminal.markets/
https://www.dxrg.ai/
https://x.com/DXRGai
https://discord.gg/dxrg

URGENT NOTE TO MEDIA: This story is developing in real-time. Trading data, agent behavior logs, and live market stats available for journalists. High-resolution graphics, technical documentation, and interviews with participants available upon request. Some participants may be willing to go on record about their strategies (or their panic).

New developer API aggregates bridging and swap liquidity to support autonomous trading and multi-chain execution

SAN FRANCISCO, Feb. 27, 2026 /PRNewswire/ — 0x, a leading decentralized exchange (DEX) infrastructure provider, today announced the launch of its Cross-Chain API to private beta, a developer solution that helps applications execute token swaps across 15+ blockchains through a single integration. The Cross-Chain API is designed to support programmatic trading and automated systems that need reliable cross-chain execution across EVM networks and Solana.

“Developers building automated trading and treasury workflows need cross-chain execution that’s fast, predictable, and easy to integrate,” said Thorsten Jaeckel, Head of Product at 0x. “With the Cross-Chain API, teams can abstract away cross-chain complexity and focus on building intelligent execution logic.”

Solving Cross-Chain Fragmentation

The 0x Cross-Chain API aggregates liquidity and routes through multiple bridge providers, automatically optimizing for best price or faster execution based on developer preferences. It enables “bridge-and-swap” experiences that settle in less than a minute (for common token pairs), packaged as a single action for the end user.

“AI agents don’t see chains, they see opportunities,” said Will Warren, co-founder and co-CEO at 0x. “Our Cross-Chain API removes the last major friction point for autonomous systems by abstracting away blockchain complexity. Developers can now build AI agents that seamlessly execute across any chain with a single API call.”

With 0x Cross-Chain API, developers can stream quotes to traders as soon as they are returned, and lower support costs through improved error tracking, delivering a more efficient and reliable cross chain experience that can be abstracted into a standard swap flow.

Key Capabilities

The 0x Cross-Chain API includes:

• Cross-chain token swaps in seconds across 15+ blockchains, including major EVM networks and Solana
• Bridge-and-swap routing backed by multiple providers, optimized for price or speed
• Intelligent routing and quotes to support automated execution workflows
• REST API with developer documentation, examples, and integration guides

Ready for Emerging Agent Standards

As stablecoins and payment standards mature, developers are increasingly experimenting with automated commerce and programmatic execution across crypto rails. Recent industry efforts include:

• Standardized, HTTP-native stablecoin payment flows (e.g., Coinbase’s x402)
• Agent-focused payment and authentication frameworks (e.g., Google’s Agent Payments Protocol and OpenAI’s Agentic Commerce Protocol)

0x Cross-Chain API is designed to integrate seamlessly with emerging payment and authentication standards for AI agents, including Coinbase’s x402 protocol (0x already powers Coinbase Developer Platform’s Swap API used in Agentic Wallets), Google’s AP2 standard, and OpenAI’s Agentic Commerce Protocol (ACP). This forward-compatible design ensures developers building on 0x today will be ready for the autonomous systems of tomorrow.

Industry research by McKinsey estimates AI agents could mediate trillions of dollars of commerce annually by 2030, increasing the need for fast and dependable cross-chain execution.

Availability and Developer Resources

The 0x Cross-Chain API Beta will be available from Feb 25, 2026 for developer integration. Documentation, code examples, and integration guides are available on the 0x website.

About 0x

0x enables customers to embed cryptocurrency trading directly in their apps, through a suite of powerful APIs and real-time analytics. 500+ teams use 0x to serve faster trades, better prices, and seamless swap experiences. Over $200 billion in volume has flowed through 0x APIs, serving 14+ million users of leading apps from Coinbase, Farcaster, Robinhood, Phantom, Metamask, Zerion, Zapper, and more.

Founded in 2017 by Will Warren and Amir Bandeali, the 0x team also runs decentralized exchange matcha.xyz, and has made significant technical contributions to crypto including the NFT token standard ERC721, and Wrapped ETH. 0x has raised $109M up to Series B from leading investors such as Pantera Capital, Greylock and Coinbase.

For more information, visit 0x.org or follow @0xproject on X.

VIENNA, Feb. 27, 2026 /PRNewswire/ — As market conditions continue to evolve and investors seek structured ways to manage digital asset exposure, Bybit EU has introduced a limited-time 3% annual percentage yield (APY) campaign across the European Economic Area (EEA), providing a defined reward mechanism within a regulated framework.

Operating under its MiCA-regulated framework, Bybit EU continues to focus on delivering compliant and transparent solutions tailored to European users. The new “Bigger Return, Shorter Hold” campaign applies a 3% APY to qualifying net top-ups maintained for a defined 180-day holding period, with a streamlined participation process that does not require enrollment in a separate staking or structured product. Users can continue to use their assets as usual on the Bybit EU platform.

A Simple Approach: Top Up, Hold, and Earn

The top-up window runs from February 25 to March 31, 2026. Participants who enroll via the official campaign landing page and make qualifying net top-ups through fiat or crypto deposits during this period will be eligible for rewards, provided they maintain their net top-up balance for 180 days from March 31, 2026.

Rewards are calculated at a 3% APY rate and distributed after successful completion of the 180-day holding period. Participation is available starting from €1 in qualifying net top-ups.

During the 180-day holding period, users may:

• Trade on spot markets
• Use spot-based strategies
• Stake eligible assets, including?
• Use their funds within the platform ecosystem

Withdrawals during this period will result in disqualification from reward eligibility.

Campaign Highlights

• Top-Up Window: February 25, 2026 – March 31, 2026
• APY: 3% annual percentage yield
• Minimum Participation: Starting from €1 up to €10,000
• Eligible Channels: Fiat deposits and crypto deposits
• Holding Period: 180 days from March 31, 2026
• Enrollment: Required via the official campaign landing page
• Reward Distribution: After successful completion of the 180-day holding period

Supporting European Users in a Changing Market Environment

In a landscape shaped by macroeconomic uncertainty and evolving investor expectations, Bybit EU seeks to provide a structured and transparent framework for users managing digital asset exposure. The campaign enables participants to maintain qualifying balances within a regulated digital asset platform while retaining the ability to trade, stake eligible assets, or hold their positions in line with their individual strategy.

Users can visit the official campaign page for full terms and participation details.

#BybitEU | #TheCryptoHub 

About Bybit EU

Bybit EU GmbH is an Austrian Crypto-Asset Service Provider (CASP) authorized under the Markets in Crypto-Assets Regulation (MiCAR) in Austria. Bybit EU serves customers across the entire European Economic Area (EEA)—with the exception of Malta—via the bybit.eu platform.

Bybit EU GmbH is authorized to offer the following services:

• custody and administration of crypto-assets on behalf of clients;
• exchange of crypto-assets for funds;
• exchange of crypto-assets for other crypto-assets;
• placing of crypto-assets; and
• transfer services for crypto-assets on behalf of clients.

Bybit EU GmbH is neither the operator of a trading platform for crypto-assets nor provides investment advice.

Media Contact: press@bybit.com

www.bybit.eu 

Disclaimer: This press release is provided for informational purposes only and does not constitute investment advice or an offer to buy or sell digital assets. The products and services mentioned herein are subject to applicable laws and regulations in the relevant jurisdictions and may not be available in certain regions

LAS VEGAS, Feb. 27, 2026 /PRNewswire/ — As severe snowstorms sweep across the nation, threatening widespread power outages and plunging temperatures, BLUETTI announces the upcoming launch of the Elite 300 portable power station. Built as a high-density energy solution in the 3kWh category, the Elite 300 provides a reliable backup for families navigating winter emergencies and a versatile power source for the upcoming RV and camping season.

3kWh Capacity with Next-Level Compactness

BLUETTI’s Elite series is globally recognized for balancing raw power with true portability. The new Elite 300 carries the legacy of the popular Elite 200 V2 portable power station, delivering an expanded 3,014.4Wh capacity within a chassis size typically reserved for 2kWh units. This industry-leading space efficiency allows it to slide neatly into tight RV quarters or compact apartments where every square foot is vital.

Despite its sleek footprint, the Elite 300 delivers a robust 2,400W continuous output (4,800W Power Lifting Mode) through 11 versatile outlets. Whether keeping the lights on during a blizzard or running high-demand appliances on the road, the Elite 300 has already earned it the prestigious 2026 CES Picks Awards from both TWICE and TechRadar Pro.

Home Resilience for Winter Storms and More Seasonal Extremes

For homeowners facing extreme weather, the Elite 300 offers a silent, emission-free take on the traditional gas generator, ensuring reliable power without the need for fuel storage. It can keep a standard household refrigerator (1kWh/day) running for nearly 60 hours, ensuring food stays fresh during prolonged outages. With its massive output, it effortlessly handles heavy-duty essentials like space heaters, electric kettles, and ovens to maintain warmth during sudden freezes.

Featuring a 10ms seamless UPS switchover, the Elite 300 provides instant backup for essential electronics like Wi-Fi routers. Through the BLUETTI App, supporting both Bluetooth and Wi-Fi connectivity, users can even remotely activate heaters or lighting via Remote Wakeup, ensuring a warm, safe home before they even step through the door. When time is of the essence, its AC and solar dual fast charging reaches 80% in just 70 minutes.

Plug-and-Play Freedom for RV, Camping & Road Trips

A game-changer for travel trailers and camper vans, the Elite 300 features 11 versatile outlets, headlined by a dedicated TT-30R RV port and a high-current 12V/30A DC output. It acts as a silent and mobile “shore power” source, keeping house batteries topped up while running AC appliances like coffee makers and electric kettles. To maximize off-grid efficiency, the 12V/30A DC port eliminates energy loss of AC-to-DC conversion, directly powering high-draw loads like diesel heaters and water pumps.

For camping, boondocking, and more off-grid road trips, the Elite 300 can be paired with the Charger 2—an alternator and solar dual charger to capture 1,200W on-the-go charging. This input is 13 times faster than a standard cigarette lighter port, ensuring even short commutes yield significant energy gains. With a full 3kWh charge achievable in about three hours of driving, the Elite 300 stands ready for immediate use upon arrival—powering camp lights, cooking appliances, or RV essentials without the typical wait for a recharge.

Pricing and Availability

The BLUETTI Elite 300 will be available starting March 8, with final retail pricing to be announced. In light of ongoing blizzard conditions, BLUETTI has also launched an Early Access Program for the Elite 300. Registered participants will receive priority shipping and a guaranteed 8% early-bird discount, along with access to an exclusive “Spin to Win” event offering savings of up to 50%—providing added support as households prepare for the next wave of extreme weather.

About BLUETTI

Founded in 2009, BLUETTI has developed into a technology pioneer in clean energy, specializing in innovative portable power stations and home battery backup solutions. With a commitment to sustainable energy storage and a growing portfolio of proprietary technologies, BLUETTI empowers over 4 million users across 110+ countries to live independent, energy-resilient lives.

CONTACT: 
Ellen Lee
PR Specialist
ellenlee@bluetti.com

MADRID, Feb. 27, 2026 /PRNewswire/ — Huawei unveiled its latest innovations at the “Now is Your Run” global product launch event in Madrid, Spain on February 26. The tech giant marked its return to professional running watches after a five-year hiatus with the debut of the all-new HUAWEI WATCH GT Runner 2. The event also showcased the HUAWEI WATCH Ultimate 2, HUAWEI Mate 80 Pro, HUAWEI MatePad Mini, HUAWEI FreeBuds Pro 5, and HUAWEI Band 11 Series. Two-time Olympic marathon champion Eliud Kipchoge was introduced as the global ambassador for HUAWEI WATCH GT Runner. “Running means much more than running fast,” said Kipchoge. “I believe that running is the most beautiful activity on every level. Together with Huawei, we can reach millions of runners around the world and hopefully impact their lives in a beautiful and positive way.”

HUAWEI WATCH GT Runner 2: Five Years of Accumulation, Redefining Professional Running Watches

HUAWEI WATCH GT Runner 2 is equipped with a new 3D floating antenna architecture, engineered to deliver unparalleled positioning precision. Equipped for the first time with an intelligent positioning algorithm, it continues to calculate the runner’s trajectory and distance even during signal interruptions, ensuring uninterrupted positioning. The new intelligent marathon mode offers one-stop race management, acting as a personal coach on your wrist throughout the journey. Not only does the HUAWEI WATCH GT Runner 2 help professional athletes boost their performance, but it also brings a smart and professional running experience to amateur runners. Eliud Kipchoge shared his experience of co-creating products with Huawei at the event, stating, “I am passionate to share my opinions and perspectives to improve the smartwatch experience not just for elite athletes but for runners all around the world.”

HUAWEI WATCH Ultimate 2 and HUAWEI Band 11 Series: Next-Level Fitness

At this event, Huawei unveiled a range of new wearable devices designed to deliver more professional and personalized fitness experiences for users. The HUAWEI WATCH Ultimate 2 debuted in a striking “Green” color, maintaining its top-tier capabilities for diving and outdoor adventures while introducing enhanced features specifically tailored for golf driving range and on-course play. This offers a more precise and intelligent high-end sports experience. Meanwhile, the HUAWEI Band 11 Series combines sleek design with practical functionality, featuring a larger and clearer display that ensures excellent visibility even under bright sunlight. Integrating health monitoring, activity tracking, and convenient features into one compact device, it serves as a reliable companion for users’ daily fitness needs.

HUAWEI Mate 80 Pro: Cutting-edge Flagship Setting New Benchmark in Mobile Experience

Huawei makes a grand return to the global market with its Mate Series, showcasing the company’s technological prowess. The HUAWEI Mate 80 Pro, representing Huawei’s cutting-edge innovation, features an upgraded True-to-Color Camera that ensures consistent color accuracy across various lighting conditions and mixed color temperatures. Its new Dual Space Ring Design, which blends classic elegance with modern aesthetics, earned widespread acclaim from attendees. With enhanced performance, 2nd Gen Kunlun Glass, and advanced AI capabilities, Huawei continues to deliver state-of-the-art technology and experiences, pushing smartphone experience to new heights.

Trendsetting Technology Unveiled for Ultimate Intelligence

Huawei unveils its first-ever Mini tablet, the HUAWEI MatePad Mini. Featuring a compact 8.8-inch body that’s slimmer and lighter than traditional tablets, it easily fits into pockets or handbags. Whether for reading documents, watching your favorite shows, or on-the-go creative work during business trips, this device is ready whenever you need it. It serves as an ideal digital companion for business professionals, avid readers, office workers, and academic researchers alike. The company also introduced the HUAWEI FreeBuds Pro 5 earbuds, the industry’s first wireless earbuds with dual-engine AI noise cancellation. Paired with a dual-drive acoustic system, they deliver exceptional noise reduction while preserving vocal and instrumental details, offering users an immersive live-listening experience.

Last year, Huawei introduced its brand proposition “Now is Yours”, aiming to establish genuine and close connections with global consumers through a more inclusive and youthful communication approach. At this “Now is Your Run” launch event, Huawei partnered with Eliud Kipchoge to promote running as a sport and advocate for a healthy lifestyle. Moving forward, Huawei will continue to promote fitness and health through technological innovation, using warm products and sincere communication to enable more people to enjoy a healthier and more vibrant life through technology.